PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM)

CUSIP: 74449F209

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Shares, without par value
Shares outstanding
4,527,832
Total 13F shares
275,000
Share change
-180,006
Total reported value
$462,000
Price per share
$1.68
Number of holders
1
Value change
+$189,166
Number of buys
1
Number of sells
8

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74449F209?
CUSIP 74449F209 identifies PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SABBY MANAGEMENT, LLC
13F
Company
5.7%
256,700
$154,020 31 Mar 2025
13F
Hudson Bay Capital Management LP
13D/G
5%
237,768
$133,150 -$79,650 31 Mar 2025
CITADEL ADVISORS LLC
13F
Company
1.7%
75,318
$45,191 31 Mar 2025
13F
Virtu Financial LLC
13F
Company
mixed-class rows
112,804
mixed-class rows
$23,000 31 Mar 2025
13F
AdvisorShares Investments LLC
13F
Company
0.78%
35,458
$20,995 31 Mar 2025
13F
UBS Group AG
13F
Company
mixed-class rows
35,148
mixed-class rows
$20,162 31 Mar 2025
13F
Harraden Circle Investments, LLC
13F
Company
class O/S missing
1,150,000
$19,435 31 Mar 2025
13F
AdvisorShares Trust
13D/G
0.79%
26,924
$15,077 $0 31 Dec 2024
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
733,000
$12,388 31 Mar 2025
13F
MMCAP International Inc. SPC
13F
Company
class O/S missing
600,000
$10,140 31 Mar 2025
13F
Calamos Advisors LLC
13F
Company
class O/S missing
500,000
$8,450 31 Mar 2025
13F
CANTOR FITZGERALD, L. P.
13F
Individual
class O/S missing
468,500
$7,918 31 Mar 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.29%
12,941
$7,765 31 Mar 2025
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
297,847
$5,049 31 Mar 2025
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
247,857
$4,201 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
200,117
$3,382 31 Mar 2025
13F
LMR Partners LLP
13F
Company
class O/S missing
200,000
$3,380 31 Mar 2025
13F
PERISCOPE CAPITAL INC.
13F
Company
class O/S missing
200,000
$3,380 31 Mar 2025
13F
CLEAR STREET LLC
13F
Company
class O/S missing
180,466
$3,050 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
175,352
$2,963 31 Mar 2025
13F
Stonehage Fleming Financial Services Holdings Ltd
13F
Company
0.1%
4,479
$2,687 31 Mar 2025
13F
TENOR CAPITAL MANAGEMENT Co., L.P.
13F
Company
class O/S missing
150,000
$2,535 31 Mar 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
147,101
$2,486 31 Mar 2025
13F
Clear Street Derivatives LLC
13F
Company
class O/S missing
109,356
$1,848 31 Mar 2025
13F
Westchester Capital Management, LLC
13F
Company
class O/S missing
92,073
$1,556 31 Mar 2025
13F
Yakira Capital Management, Inc.
13F
Company
class O/S missing
76,843
$1,298 31 Mar 2025
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
50,000
$1,000 31 Mar 2025
13F
LPL Financial LLC
13F
Company
class O/S missing
29,345
$496 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
20,923
$354 31 Mar 2025
13F
Ancora Advisors LLC
13F
Company
class O/S missing
5,000
$84 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0%
69
$41 31 Mar 2025
13F

Institutional Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) as of Q2 2025

As of 30 Jun 2025, PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 275,000 shares. The largest 1 holders included Parallel Advisors, LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
8
Q2 2025 holders
1
Holder diff
-7
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.